Senate LDA lobbying filing
CENCORA, INC.
Reported income
not reported
Reported expenses
$510.0K
Tracked program mentions4
Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.
Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/ Main Street Pharmacy Access Act (H.R. 3164)…
- Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chain”matched 2+ title words
Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile Prescription…
Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/ Main Street Pharmacy Access Act (H.R. 3164)…
Tariff proposed policies H.R.2213 - Medical Supply Chain Resiliency Act
Lobbying activities5
Health IssuesHCR
Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pharmaceutical supply chain resilience National Defense Authorization Act (NDAA - H.R.8800) Supply Chain Resiliency Most Favored Nation drug pricing proposals Direct to Consumer proposals CMS FY 2026 Medicares Part B Physician Fee Schedule Rule CMS ASP Certification Break Up Big Medicine Act (S. 3822) Management Services Organization (MSO) Role and value of community specialty physicians and MSOs Pandemic and All-Hazards Preparedness/Protecting Americans from All Hazards Preparedness Act (PAHPA) Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299)
Medicare/MedicaidMMM
Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/ Main Street Pharmacy Access Act (H.R. 3164)/ Equitable Community Access to Pharmacist Services Act (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R 4299) Reimbursement policies impacting drug shortage Part B drug pricing changes Preventing and mitigating generic drug shortages CMS FY 2026 Medicares Part B Physician Fee Schedule CMS ASP Certification Medicare physician reimbursement CY2026 Medicare Physician Fee Schedule Rule Distributor bona fide service fees
PharmacyPHA
Preventing and mitigating generic drug shortages Ensuring Seniors Access to Critical Medications Act/ Main Street Pharmacy Access Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act (S.2426) Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) Support for Fair Pharmacy Reimbursement
Taxation/Internal Revenue CodeTAX
Global Intangible Low-taxed Income (GILTI) Territorial Economic Recovery Act (H.R. 363) The Medical Manufacturing, Economic Development, and Sustainability (MMEDS) Act (H.R. 3042) Restore Economic Vitality and Investment in the Virgin Islands Act (REVIVE VI Act) (858)
Trade (domestic/foreign)TRD
Tariff proposed policies H.R.2213 - Medical Supply Chain Resiliency Act
Lobbyists5
- COREY MCGEE
- DARRELL ROGERS
- FREDERICK ESSIS
- SHELLY MUI-LIPNIK
- VIVIENNE MITCHELL
Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.